Erick Gamelin
Förmögenhet: 78 888 $ per 2026-07-31
Förmögenhet: 78 888 $ per 2026-07-31
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-18 | 52 592 ( 0,12 % ) | 78 888 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Företagsledare/Principal | 2024-01-03 |
| Företag | Position | Slut |
|---|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Teknisk/Vetenskaplig/F&U Direktör | 2021-01-01 |
| DYNAVAX TECHNOLOGIES CORPORATION | Företagsledare/Principal | 2019-10-01 |
| MACROGENICS, INC. | Företagsledare/Principal | 2018-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån